Jump to main content
Jump to site search

Issue 85, 2012
Previous Article Next Article

A covalently reactive group-modified peptide that specifically reacts with lysine16 in amyloid β

Author affiliations

Abstract

Lys16 is present in the core region of the amyloid β (Aβ) self-assembly in Alzheimer's disease. Here we report that the P9-NCS peptide can covalently react with Lys16 and inhibit Aβ neurotoxic fibrillization. Moreover P9-NCS has high selectivity and it cannot react with amylin, insulin, fetal bovine serum, Q11 and MUC1 peptide.

Graphical abstract: A covalently reactive group-modified peptide that specifically reacts with lysine16 in amyloid β

Back to tab navigation

Supplementary files

Publication details

The article was received on 19 Jul 2012, accepted on 02 Sep 2012 and first published on 03 Sep 2012


Article type: Communication
DOI: 10.1039/C2CC35178A
Citation: Chem. Commun., 2012,48, 10565-10567
  •   Request permissions

    A covalently reactive group-modified peptide that specifically reacts with lysine16 in amyloid β

    J. Ma, L. Zhao, D. Zhao, Q. Liu, C. Liu, W. Wu, Y. Chen, Y. Zhao and Y. Li, Chem. Commun., 2012, 48, 10565
    DOI: 10.1039/C2CC35178A

Search articles by author

Spotlight

Advertisements